Bio-Techne TECH EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's EPS (diluted)?
- Bio-Techne (TECH) reported EPS (diluted) of $0.32 in Q1 2026.
- How has Bio-Techne's EPS (diluted) changed year-over-year?
- Bio-Techne's EPS (diluted) increased by 128.6% year-over-year, from $0.14 to $0.32.
- What is the long-term trend for Bio-Techne's EPS (diluted)?
- Over 2 years (2022 to 2024), Bio-Techne's EPS (diluted) has grown at a -40.1% compound annual growth rate (CAGR), from $2.93 to $1.05.
- What does EPS (diluted) mean?
- Profit per share assuming all potential stock options and convertible securities are exercised.
- How do you interpret EPS (diluted)?
- A higher value indicates strong earnings power even when accounting for potential share dilution.
- How does EPS (diluted) compare across companies?
- The standard metric used by analysts to evaluate earnings performance while accounting for capital structure complexity.